Literature DB >> 10814799

Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue.

M A De Letter1, P A van Doorn, H F Savelkoul, J D Laman, P I Schmitz, A A Op de Coul, L H Visser, J M Kros, J L Teepen, F G van der Meché.   

Abstract

In a longitudinal prospective study a muscle biopsy was taken from 30/32 (33%) of the 98 patients who developed critical illness polyneuropathy and myopathy (CIPNM). Neuropathic changes were found in 37%, myopathic in 40%, and a combination in 23% of the biopsies. The immunohistopathology showed macrophages and Th-cells in 40% and 60% of the muscle biopsies respectively. Small mainly perivascular infiltrates contained macrophages and Th-cells. ICAM-1, VCAM and MAC were found on the vascular endothelium in 58%, 53% and 79% respectively. In all biopsies there was an upregulation of both HLA-I and HLA-DR. Proinflammatory cytokines and TNFalphaR75 were also produced locally (IL-1beta in 71%, IFN-gamma in 40%, IL-12 in 73%, TNFalphaR75 in 90%). The anti-inflammatory cytokine IL-10 was simultaneously expressed in 96% of the biopsies. HLA-DR, TNFalphaR75 and IL-10 differed significantly when compared with control muscle biopsies. Our data provide evidence that small numbers of activated leukocytes producing both pro- and anti-inflammatory cytokines infiltrate skeletal muscle of CIPNM patients. We propose that the local balance of leukocyte activities is of importance in the pathophysiology of muscle weakness in CIPNM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814799     DOI: 10.1016/s0165-5728(99)00252-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  33 in total

1.  Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both?

Authors:  Nicola Latronico
Journal:  Intensive Care Med       Date:  2003-09       Impact factor: 17.440

Review 2.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

Review 3.  [Cellular regulation of anabolism and catabolism in skeletal muscle during immobilisation, aging and critical illness].

Authors:  Eva-Maria Strasser; Barbara Wessner; Erich Roth
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 4.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

Review 5.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

6.  IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?

Authors:  Oliver Friedrich; Bing Yi; Joshua N Edwards; Barbara Reischl; Anette Wirth-Hücking; Andreas Buttgereit; Roland Lang; Cornelia Weber; Fabian Polyak; Ilon Liu; Frederic von Wegner; Tanya R Cully; Aven Lee; Patrick Most; Mirko Völkers
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

7.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

Review 8.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

9.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity.

Authors:  Josef Bednarik; Zdenek Lukas; Petr Vondracek
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

10.  Myofibrillar protein and gene expression in acute quadriplegic myopathy.

Authors:  Holly Norman; Håkan Zackrisson; Yvette Hedström; Per Andersson; Jenny Nordquist; Lars I Eriksson; Rolf Libelius; Lars Larsson
Journal:  J Neurol Sci       Date:  2009-06-06       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.